Loading Pathway...
Error: Pathway image not found.
Hide
Pathway Description
Physostigmine Action Pathway
Homo sapiens
Drug Action Pathway
Physostigmine is a cholinesterase inhibitor used to treat glaucoma, once administered it is rapidly absorbed and can travel across membranes even the blood-brain barrier. Physostigmine acts on the acetylcholinesterase enzyme and inhibits it so it cannot break down acetylcholine. By doing so it keeps acetylcholine available within the synaptic cleft continuing to act on nicotinic and muscarinic receptors.
References
Physostigmine Pathway References
Andrade OA, Zafar Gondal A: Physostigmine.
Pubmed: 31424845
Andrade OA, Zafar Gondal A. Physostigmine. [Updated 2023 Apr 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK545261/
Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T: Safety and effectiveness of physostigmine: a 10-year retrospective review<sup/>. Clin Toxicol (Phila). 2018 Feb;56(2):101-107. doi: 10.1080/15563650.2017.1342828. Epub 2017 Jul 13.
Pubmed: 28703024
Highlighted elements will appear in red.
Highlight Compounds
Highlight Proteins
Enter relative concentration values (without units). Elements will be highlighted in a color gradient where red = lowest concentration and green = highest concentration. For the best results, view the pathway in Black and White.
Visualize Compound Data
Visualize Protein Data
Downloads
Settings